Van Hulzen Asset Management LLC Purchases 3,041 Shares of CME Group Inc. $CME

Van Hulzen Asset Management LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 10.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,062 shares of the financial services provider’s stock after buying an additional 3,041 shares during the period. Van Hulzen Asset Management LLC’s holdings in CME Group were worth $6,860,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC raised its stake in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership bought a new stake in CME Group during the fourth quarter worth $27,000. Hilton Head Capital Partners LLC purchased a new stake in CME Group in the 4th quarter valued at $28,000. Main Street Group LTD bought a new position in CME Group during the 1st quarter valued at $32,000. Finally, Bayban bought a new position in CME Group during the 4th quarter valued at $31,000. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on CME shares. Bank of America increased their target price on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Morgan Stanley upped their price objective on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. Piper Sandler dropped their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Finally, TD Cowen reaffirmed a “buy” rating and set a $292.00 price target on shares of CME Group in a research report on Thursday, September 3rd. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus target price of $289.75.

Insider Activity at CME Group

In other CME Group news, Director William Shepard acquired 325 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.30% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Shareholder distribution: CME is scheduled to distribute approximately $467 million in dividends on September 25, reinforcing its appeal to income-oriented investors and highlighting the exchange operator’s strong cash-generation profile. CME Group’s $467 Million Dividend: What Shareholders Collect Sept. 25
• Positive Sentiment: Product expansion: CME’s new single-stock futures offer investors leveraged and capital-efficient exposure to individual equities. The product broadens CME’s equity derivatives lineup and could create additional trading volume and fee revenue over time. CME’s New Single Stock Futures: What Are The Advantages Vs. Stocks?
• Positive Sentiment: European market entry: CME plans to enter the European dairy market through a deal involving EEX, expanding its addressable market and potentially improving its international commodities presence. CME Group to enter European dairy market through EEX deal
• Neutral Sentiment: Leadership succession: CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. The planned internal transition may provide continuity, although investors could monitor execution during the leadership change. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Interest-rate backdrop: Reports that Federal Reserve Chair Warsh favors rate hikes, while the Treasury considers buying longer-maturity debt, point to continued uncertainty over rates, inflation and bond-market conditions. These factors can affect CME’s interest-rate and fixed-income trading volumes. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation: The Hyperliquid Policy Center filed an amicus brief urging dismissal of CME’s lawsuit against the CFTC. The development adds uncertainty to CME’s regulatory position and could weigh on sentiment surrounding its digital-asset and derivatives initiatives. Hyperliquid Policy Center Files Amicus Brief Urging Dismissal of CME’s Suit Against CFTC

CME Group Stock Performance

Shares of CME stock opened at $274.70 on Thursday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $98.78 billion, a price-to-earnings ratio of 23.30, a P/E/G ratio of 3.29 and a beta of 0.24. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The firm’s 50-day simple moving average is $262.03 and its two-hundred day simple moving average is $277.67.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the firm posted $2.96 EPS. CME Group’s revenue was up .8% on a year-over-year basis. As a group, equities analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is 44.11%.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.